BioSpace News Archive

Healthy Directions LLC, a subsidiary of Adaptive Health, LLC, is proud to announce its newly signed partnership with Dr. Briana Sinatra, a practicing, board-certified naturopathic physician with a focus on women’s and family health and wellness.

MedCerts, an education provider of next-generation online career and certification training, launched a Patient Care Technician program adding to their growing list of over 40 programs

To address an urgent shortage of healthcare professionals needed to navigate an increasingly complex healthcare system, Western Governors University (WGU) is now offering a first-of-its-kind Bachelor of Science Health Services Coordination (BSHSC) degree program.

A recent Gallup poll reveals what too many Americans already know to be true: healthcare is becoming less and less affordable.

Illinois Bone & Joint Institute (IBJI), one of the largest independent, physician-owned orthopedic practices in the United States, is excited to welcome Sheela Metgud, MD, fellowship-trained rheumatologist.

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today announced that Joseph Darling, President and Chief Executive Officer, and Sylvia Cheung, Chief Financial Officer, will participate in a fireside chat at the 2019 Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2019 at 8:35 am ET.

Deciphera Pharmaceuticals, Inc. (Nasdaq:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced that the underwriters of its previously announced public offering of common stock have exercised their option to purchase an additional 1,621,621 shares of the Company’s common stock at a price of $37.00 per share before underwriting discounts.

Castle Biosciences, Inc. (Nasdaq: CSTL) today announced its financial results for the second quarter and six months ended June 30, 2019.

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that Blue Cross Blue Shield of Massachusetts and Blue Cross Blue Shield of Idaho are now providing coverage for Eversense CGM.

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced an agreement with Verseau Therapeutics for the delivery of systems pharmacology pharmacokinetic and target engagement analysis to provide early feasibility assessments for the treatment of cancer.